DOD Biotech PCL Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	52.64	129.23	223.09	67.99	30.27	161.68
Short-Term Investments	-	160.77	-	-	-	-
Trading Asset Securities	-	0.03	-	-	-	-
Cash & Short-Term Investments	52.64	290.02	223.09	67.99	30.27	161.68
Cash Growth	-76.40%	30.00%	228.12%	124.62%	-81.28%	13.06%
Accounts Receivable	95.55	52.63	24.37	82.29	39.05	315.37
Other Receivables	-	19.56	17.74	29.26	17.69	22.07
Receivables	95.55	72.19	42.1	111.55	56.74	337.44
Inventory	98	111.92	126.88	150.4	98.03	113.46
Other Current Assets	139.52	23.2	224.48	42.01	12.09	13.42
Total Current Assets	385.71	497.33	616.55	371.96	197.13	626
Property, Plant & Equipment	501.2	507.66	511.33	915.83	963	961.03
Long-Term Investments	2.77	2.77	2.6	2.6	2.6	2.6
Goodwill	0.25	0.25	0.25	0.25	-	-
Other Intangible Assets	35.35	37.04	43.06	50.48	5.57	5.66
Long-Term Deferred Tax Assets	93.57	92.6	95.5	90.64	92.54	7.9
Other Long-Term Assets	110.27	16.31	17.02	25.89	30.08	23.8
Total Assets	1,130	1,154	1,286	1,458	1,291	1,627
Accounts Payable	72.99	42.67	39.23	75.4	80.44	93.09
Accrued Expenses	2.74	24.08	22.5	25.25	17.17	13.64
Short-Term Debt	-	-	45	110.49	148.7	77
Current Portion of Long-Term Debt	12.92	12.92	-	2.12	19.81	28.76
Current Portion of Leases	0.11	0.29	0.77	2.8	2.62	4.92
Current Income Taxes Payable	-	1.96	1.72	21.18	1.66	-
Current Unearned Revenue	27.18	18.67	234.83	27.23	-	-
Other Current Liabilities	1.68	15.61	21.93	18.32	33.71	41.74
Total Current Liabilities	117.62	116.19	365.98	282.8	304.11	259.16
Long-Term Debt	53.91	57.14	-	-	2.12	19.31
Long-Term Leases	-	-	0.29	53.29	55.82	53.31
Pension & Post-Retirement Benefits	10.07	13.34	10.59	10.72	7.68	5.37
Long-Term Deferred Tax Liabilities	6.63	6.92	10.95	18.49	10.68	12.05
Other Long-Term Liabilities	6.6	6.53	6.6	12.29	16.87	15.5
Total Liabilities	194.83	200.13	394.4	377.58	397.29	364.7
Common Stock	225.21	225.21	225.21	225.21	205	205
Additional Paid-In Capital	651.33	651.33	947.27	1,051	890.85	890.85
Retained Earnings	62.95	81.79	-273.87	-225.16	-233.86	164.47
Comprehensive Income & Other	-	-	-	7.35	25.17	20.24
Total Common Equity	939.48	958.33	898.6	1,058	887.15	1,281
Minority Interest	-4.47	-4.49	-6.69	22.12	6.48	-18.26
Shareholders' Equity	935.02	953.84	891.91	1,080	893.63	1,262
Total Liabilities & Equity	1,130	1,154	1,286	1,458	1,291	1,627
Total Debt	66.94	70.35	46.06	168.69	229.08	183.3
Net Cash (Debt)	-14.3	219.68	177.03	-100.7	-198.81	-21.62
Net Cash Growth	-	24.09%	-	-	-	-
Net Cash Per Share	-0.03	0.49	0.39	-0.23	-0.48	-0.05
Filing Date Shares Outstanding	450.41	450.41	450.41	450.41	410	410
Total Common Shares Outstanding	450.41	450.41	450.41	450.41	410	410
Working Capital	268.08	381.14	250.58	89.16	-106.98	366.85
Book Value Per Share	2.09	2.13	2.00	2.35	2.16	3.12
Tangible Book Value	903.88	921.03	855.29	1,007	881.58	1,275
Tangible Book Value Per Share	2.01	2.04	1.90	2.24	2.15	3.11
Land	-	153.48	153.48	218.87	218.87	218.87
Buildings	-	343.16	330.42	629.76	535.29	482.56
Machinery	-	233.26	199.85	297.4	275.58	228.29
Construction In Progress	-	10.91	26.62	13.71	109.92	159.25